NYSE$UNH
UnitedHealth · Q3 2025 earnings
Q3 2025 earnings · · Before market open · Investor relations
Briefing
UnitedHealth Group reported Q3 2025 total revenues of $113.2B with net earnings of $2.5B and diluted EPS of $2.59.
Third-quarter total revenues were $113.2 billion with net earnings of $2.5 billion and diluted EPS of $2.59. UnitedHealthcare and Optum segments drove the top line while medical cost trends and prior-period development influenced earnings quality versus the prior year.
- Q3 total revenues $113.2B; diluted EPS $2.59.
- UnitedHealthcare membership and Optum services support scale.
- Medical care ratio and utilization remain investor focal points.
- Capital deployment balances growth investments and returns.
Headline financials
Revenue & EPS history
UnitedHealth · Revenue · Quarterly
$113B
Revenue by segment
UnitedHealth · $92.4B total across 4 segments · Q3 2023
- Premiums$72.3B+12.2%78.3%
- Products$10.4B+12.7%11.2%
- Services$8.67B+29.4%9.4%
- Investment & Other$997M+94.3%1.1%
Forward guidance
The release discusses UnitedHealth Group's outlook, capital allocation, and key risks for upcoming quarters, including guidance ranges or operating priorities where disclosed.
Tailwinds
- Management discussed operating priorities and capital allocation for upcoming quarters.
- UnitedHealth Group cites demand and execution supporting the near-term outlook.
- Liquidity and balance-sheet capacity support operations and shareholder returns.
Headwinds
- Macro, input costs, and FX may pressure margins quarter to quarter.
- Segment mix and one-time items can affect comparability versus prior periods.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2025
+0.9%
Avg return
Earnings day
+1.3%
Avg return
5 days after
+2.6%
Avg return
30 days after
63%
46 / 73 earnings
Positive
+11.2%
Q2 2024
Best reaction
-22.4%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | +9.7% | +18.1% | |
| Q4 2025 | -11.2% | -18.4% | -18.5% | |
| Q3 2025 | +0.1% | -6.7% | -9.9% | |
| Q2 2025 | +0.6% | +21.2% | +38.2% | |
| Q1 2025 | -22.4% | -27.0% | -50.1% | |
| Q4 2024 | -6.2% | -3.4% | -3.7% | |
| Q3 2024 | -5.6% | -5.9% | -2.0% | |
| Q2 2024 | +11.2% | +9.7% | +12.5% | |
| Q1 2024 | +7.5% | +12.5% | +17.0% | |
| Q4 2023 | -3.8% | -2.7% | -4.0% | |
| Q3 2023 | +2.4% | +2.0% | +3.0% | |
| Q2 2023 | +8.1% | +12.5% | +13.5% | |
| Q1 2023 | -4.0% | -7.6% | -6.7% | |
| Q4 2022 | -2.1% | -3.9% | -0.3% | |
| Q3 2022 | +2.3% | +2.0% | +2.4% | |
| Q2 2022 | +3.4% | +3.4% | +8.2% | |
| Q1 2022 | -0.5% | +0.1% | -9.6% | |
| Q4 2021 | +0.4% | +0.3% | +1.5% | |
| Q3 2021 | +6.1% | +5.2% | +13.7% | |
| Q2 2021 | +1.2% | -0.4% | -1.2% | |
| Q1 2021 | +4.1% | +5.6% | +9.1% | |
| Q4 2020 | +0.8% | -1.2% | -7.8% | |
| Q3 2020 | -2.1% | -2.2% | +7.3% | |
| Q2 2020 | -0.4% | -1.6% | +4.9% | |
| Q1 2020 | +10.3% | +4.3% | +7.6% | |
| Q4 2019 | +4.3% | +3.5% | +3.7% | |
| Q3 2019 | +7.4% | +11.2% | +16.0% | |
| Q2 2019 | -3.8% | -4.4% | -7.9% | |
| Q1 2019 | -5.8% | -3.7% | +2.9% | |
| Q4 2018 | +5.4% | +7.0% | +7.0% | |
| Q3 2018 | +2.7% | +1.9% | +1.8% | |
| Q2 2018 | -0.6% | -1.7% | +2.4% | |
| Q1 2018 | +2.6% | +2.1% | +5.5% | |
| Q4 2017 | +4.3% | +6.4% | -1.1% | |
| Q3 2017 | +6.2% | +7.4% | +9.3% | |
| Q2 2017 | +1.5% | +2.9% | +3.4% | |
| Q1 2017 | +1.2% | +2.4% | +2.6% | |
| Q4 2016 | -2.5% | -1.9% | +1.1% | |
| Q3 2016 | +7.6% | +8.4% | +12.4% | |
| Q2 2016 | +1.6% | +2.1% | +1.0% | |
| Q1 2016 | +4.8% | — | — | |
| Q4 2015 | +5.1% | — | — | |
| Q3 2015 | -1.7% | — | — | |
| Q2 2015 | -1.6% | — | — | |
| Q1 2015 | +1.2% | — | — | |
| Q4 2014 | +7.8% | — | — | |
| Q3 2014 | +7.3% | — | — | |
| Q2 2014 | +2.1% | — | — | |
| Q1 2014 | -4.1% | — | — | |
| Q4 2013 | -3.1% | — | — | |
| Q3 2013 | -8.6% | — | — | |
| Q2 2013 | +7.9% | — | — | |
| Q1 2013 | -3.2% | — | — | |
| Q4 2012 | +1.7% | — | — | |
| Q3 2012 | -2.6% | — | — | |
| Q2 2012 | -1.7% | — | — | |
| Q1 2012 | +3.8% | — | — | |
| Q4 2011 | +2.3% | — | — | |
| Q3 2011 | -2.2% | — | — | |
| Q2 2011 | -1.7% | — | — | |
| Q1 2011 | +0.5% | — | — | |
| Q4 2010 | +0.7% | — | — | |
| Q3 2010 | -0.5% | — | — | |
| Q2 2010 | +1.6% | — | — | |
| Q1 2009 | -0.8% | — | — | |
| Q1 2010 | -0.2% | — | — | |
| Q4 2009 | +0.4% | — | — | |
| Q4 2007 | +0.4% | — | — | |
| Q3 2008 | +5.5% | — | — | |
| Q3 2009 | +5.5% | — | — | |
| Q4 2008 | +1.3% | — | — | |
| Q2 2008 | +1.3% | — | — | |
| Q2 2009 | +1.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro